Archive: 27/09/2015

Rare cancer responds unusually well to new treatment

Vienna, Austria: Patients with advanced gastrointestinal neuroendocrine tumours (NETs) have limited treatment options and there are few oncologists who are specialised in this relatively rare disease. But now results from ...

page 1 from 2